Skip to content
A3849Assembly2019-2020 SessionSame asS5296

Let Doctors, Pharmacists Team Up

Official title

“Authorizes physicians and pharmacists to enter into comprehensive medication management protocols for their patients”

Sponsor John T. McDonald IIIAD-108+30 co-sponsorsAffects Education
Status
In Assembly Committee
Higher Education
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill authorizes qualified pharmacists to provide comprehensive medication management for chronic diseases under physician-approved protocols and makes related collaborative practice provisions permanent.

Why it matters

  1. Expands the role of pharmacists in patient care. by allowing "qualified pharmacists" to directly manage and adjust medication regimens for chronic disease patients, in close collaboration with physicians, which could improve medication safety and treatment outcomes for complex cases.

  2. Strengthens patient safety and oversight. by requiring all medication adjustments by pharmacists to be documented in medical records and communicated promptly to the treating physician, ensuring that physicians remain informed and in control of their patients’ overall care plans.

  3. Patient participation is strictly voluntary. patients (or their representatives) must provide written consent before beginning comprehensive medication management, and can withdraw at any time, protecting patient autonomy and choice in their healthcare.

  4. Makes collaborative practice provisions permanent. removing previous sunset clauses ensures ongoing continuity and stability in pharmacist-physician collaborative care programs, potentially encouraging more healthcare providers to adopt these team-based approaches for chronic disease management.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Watching

    Qualified pharmacists

    The bill would let them adjust medication regimens and, when specifically authorized, order related laboratory tests and perform routine monitoring under written physician protocols.

  • Treating physicians

    They could voluntarily establish medication management protocols with qualified pharmacists while retaining authority to prohibit medication changes.

  • Patients with chronic diseases

    They could receive pharmacist-led medication management with written consent and could stop participating at any time.

  • Pharmacists and physicians practicing collaborative drug therapy management

    The bill would remove the July 1, 2020 expiration of provisions authorizing that practice in certain settings.

Headline styles

Let Doctors, Pharmacists Team Up

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Referred to higher education
  2. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S5296Senate

Let Doctors, Pharmacists Manage Meds

In Senate Committee · Health · Sponsor Neil D. Breslin

Impact 7 · Significant0% to pass

Full text

4 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

3849

2019-2020 Regular Sessions

IN ASSEMBLY

January 31, 2019

Introduced by M. of A. McDONALD, MOSLEY, ORTIZ, D'URSO, BENEDETTO, SEAWRIGHT, JOYNER, CROUCH, GIGLIO, NIOU, CAHILL, WRIGHT, LAWRENCE, STECK, JONES, LUPARDO, COLTON, DICKENS, FAHY, LIFTON, RA -- Multi- Sponsored by -- M. of A. ENGLEBRIGHT, HAWLEY -- read once and referred to the Committee on Higher Education

AN ACT to amend the public health law and the education law, in relation to comprehensive medication management; and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, in relation to making the provisions of such chapter permanent

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new article 29-H to read as follows:

ARTICLE 29-H

COMPREHENSIVE MEDICATION MANAGEMENT Section 2999-ee. Comprehensive medication management.

§ 2999-ee. Comprehensive medication management. 1. Definitions. As used in this article, the following terms shall have the following meanings:

(a) Qualified pharmacist. The term "qualified pharmacist" shall mean a pharmacist who maintains a current unrestricted license pursuant to article one hundred thirty-seven of the education law, who has a minimum of two years of experience in patient care as a practicing pharmacist within the last five years, and who has demonstrated competency in the medication management of patients with a chronic disease or diseases, including, but not limited to, the completion of one or more programs which are accredited by the accreditation council for pharmacy education, recognized by the education department and acceptable to the patient's treating physician.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00591-01-9

A. 3849 2

(b) Patient care. The term "patient care" shall mean assessing the appropriateness of prescription and non-prescription drugs for individual patients based on an assessment of the patient's medication history, medication experience including beliefs, concerns, understanding and expectations, the clinical goals of therapy, potential drug-to-drug interactions or other medication safety concerns, recommendations for adherence and consulting with a patient or caregiver.

(c) Comprehensive medication management. The term "comprehensive medication management" shall mean a program conducted by a qualified pharmacist that ensures a patient's medications, whether prescription or nonprescription, are individually assessed to determine that each medication is appropriate for the patient, effective for the medical condition, safe given the comorbidities and other medications being taken, and able to be taken by the patient as intended. Comprehensive medication management conducted by a qualified pharmacist shall include sharing of applicable patient clinical information with the treating physician as specified in a comprehensive medication management protocol.

(d) Comprehensive medication management protocol. The term "comprehensive medication management protocol" shall mean a written document pursuant to and consistent with any applicable state and federal requirements, that is entered into voluntarily by a physician licensed pursuant to article one hundred thirty-one of the education law and a qualified pharmacist which addresses a chronic disease or diseases as determined by the treating physician and that describes the nature and scope of the comprehensive medication management services to be performed by the qualified pharmacist, in accordance with the provisions of this article. Comprehensive medication management protocols between licensed physicians and qualified pharmacists shall be made available to the department for review and to ensure compliance with this article, upon request.

2. Authorization to establish comprehensive medication management protocols. A physician licensed pursuant to article one hundred thirtyone of the education law shall be authorized to voluntarily establish a comprehensive medication management protocol with a qualified pharmacist to provide comprehensive medication management services for a patient who has not met clinical goals of therapy, is at risk for hospitalization or for whom the physician deems it is necessary to receive comprehensive medication management services. Participation by the patient in comprehensive medication management services shall be voluntary.

3. Scope of comprehensive medication management protocols. Under a comprehensive medication management protocol, a qualified pharmacist shall be permitted to:

(a) adjust or manage a drug regimen of a patient, pursuant to the patient specific order or protocol established by the patient's treating physician, which may include adjusting drug strength, frequency of administration or route of administration. Adjusting the drug regimen shall not include substituting or selecting a different drug which differs from that initially prescribed by the patient's treating physician unless such substitution is expressly authorized in the written order or protocol. The qualified pharmacist shall be required to immediately document in the patient's medical record changes made to the patient's drug therapy. The patient's treating physician may prohibit, by written instruction, any adjustment or change in the patient's drug regimen by the qualified pharmacist;

(b) evaluate and, only if specifically authorized by the protocol and only to the extent necessary to discharge the responsibilities set forth

A. 3849 3

in this article, order disease state laboratory tests related to the drug therapy management for the specific chronic disease or diseases specified within the written agreement or protocol;

(c) only if specifically authorized by the written order or protocol and only to the extent necessary to discharge the responsibilities set forth in this article, order or perform routine patient monitoring functions as may be necessary in the drug therapy management, including the collecting and reviewing of patient histories, and ordering or checking patient vital signs, including pulse, temperature, blood pressure, weight and respiration; and

(d) access the complete patient medical record maintained by the treating physician with whom the qualified pharmacist has the comprehensive medication management protocol and document any adjustments made pursuant to the protocol in the patient's medical record and shall notify the patient's treating physician of any adjustments in a timely manner electronically or by other means.

(e) Under no circumstances, shall the qualified pharmacist be permitted to delegate comprehensive medication management services to any other licensed pharmacist or other pharmacy personnel.

4. Medication adjustments. Any medication adjustments made by the qualified pharmacist pursuant to the comprehensive medication management protocol including adjustments in drug strength, frequency or route of administration, or initiation of a drug which differs from that initially prescribed and as documented in the patient's medical record shall be deemed an oral prescription authorized by an agent of the patient's treating physician and shall be dispensed consistent with section sixty-eight hundred ten of the education law. For the purposes of this article, a pharmacist who is not an employee of the physician may be authorized to serve as an agent of the physician.

5. Referrals. A physician licensed pursuant to article one hundred thirty-one of the education law who has responsibility for the treatment and care of a patient for a chronic disease or diseases as determined by the physician may refer the patient to a qualified pharmacist for comprehensive medication management services, pursuant to the comprehensive medication management protocol that the physician has established with the qualified pharmacist. The protocol agreement shall authorize the pharmacist to serve as an agent of the physician as defined by the protocol. Such referral shall be documented in the patient's medical record.

6. Patient participation. Participation in comprehensive medication management services shall be voluntary, and no patient, physician or pharmacist shall be required to participate. The referral of a patient for comprehensive medication management services and the patient's right to choose to not participate shall be disclosed to the patient. Comprehensive medication management services shall not be utilized unless the patient or the patient's authorized representative consents, in writing, to such services. Such consent shall be noted in the patient's medical record. If the patient or the patient's authorized representative who consented chooses to no longer participate in such services, at any time, the services shall be discontinued and it shall be noted in the patient's medical record.

§ 2. The education law is amended by adding a new section 6801-b to read as follows:

§ 6801-b. Comprehensive medication management. 1. As used in this section:

A. 3849 4

(a) "comprehensive medication management" shall mean a program for the management of chronic disease or diseases that ensures a patient's medications, whether prescription or nonprescription, are individually assessed to determine that each medication is appropriate for the patient, effective for the medical condition, safe given the comorbidities and other medications being taken, and able to be taken by the patient as intended; and

(b) "comprehensive medication management protocol" shall mean a written document, pursuant to and consistent with any applicable state or federal requirements, that is entered into voluntarily by a physician licensed pursuant to article one hundred thirty-one of this title and a licensed pharmacist who meets the qualification requirements specified in article twenty-nine-H of the public health law which addresses a chronic disease or diseases as determined by the physician and that describes the nature and scope of the comprehensive medication management service to be performed by the qualified pharmacist. Comprehensive medication management protocols between licensed physicians and qualified pharmacists shall be made available to the department for review and to ensure compliance with this article, upon request.

2. A licensed pharmacist qualified pursuant to article twenty-nine-H of the public health law is authorized to serve as an agent of the physician when executing the terms of the written comprehensive medication management protocol as established by the licensed physician for the management of patients with a chronic disease or diseases.

§ 3. Section 5 of chapter 21 of the laws of 2011, amending the education law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, as amended by section 5 of part DD of chapter 57 of the laws of 2018, is amended to read as follows:

§ 5. This act shall take effect on the one hundred twentieth day after it shall have become a law[, provided, however, that the provisions of sections two, three, and four of this act shall expire and be deemed repealed July 1, 2020]; provided, however, that the amendments to subdivision 1 of section 6801 of the education law made by section one of this act shall be subject to the expiration and reversion of such subdivision pursuant to section 8 of chapter 563 of the laws of 2008, when upon such date the provisions of section one-a of this act shall take effect; provided, further, that effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

§ 4. This act shall take effect immediately, provided that sections one and two of this act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.